Opening session of the 4th South African AIDS Conference in Durban in 2009. Professor Linda Gail Bekker from University of Cape Town talks about the HIV/AIDS situation in South Africa. The film also includes music performances and location shots.

XVII International AIDS Conference in Mexico City. Interview with three pioneers in the HIV/AIDS response - Dr Mervyn Silverman, Dr Paul Volberding, and Dr Lars Olof Kallings. They talk about the history of the AIDS movement.

XVII International AIDS Conference in Mexico City. Interview with MD Mubashar Sheikh, Executive Director of Global Health Workforce Alliance at WHO. He talks about international cooperation and leadership in HIV/AIDS policy and the HIVAIDS situation in Iran and Pakistan.

XVII International AIDS Conference in Mexico City. Interview with MD Mubashar Sheikh, Executive Director of Global Health Workforce Alliance at WHO. He talks about international cooperation and leadership in HIV/AIDS policy and the HIVAIDS situation in Iran and Pakistan.

Interview with Daniel Tarantola, Professor of Health and Human Rights at University of New South Wales in Sydney. He tells about his work in expanding health care services in several African countries, starting in the early 1970's and the time when he entered the HIV field.

Mr Subbarao is secretary of state for health in the Tamil Nadu Government in Chennai. In this interview he talks about the educational and medical work lead by the government. He talks particularly about empowering and educate women about HIV prevention.

XVI International AIDS Conference in Toronto in August, 2006. Closing session with music performance and presentations of the Mexican representatives of the International AIDS Society. They speak about the 2008 International AIDS Conference in Mexico.

Sten Vermund from University of Alabama reflects on the history of the global AIDS epidemic and his involvement in the field as a young scientist in the 80's. He discusses the social and economic factors of HIV/AIDS, such as stigma, poverty and the drug industry.